Overview

A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension

Status:
COMPLETED
Trial end date:
2024-12-04
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to assess the serum free cortisol response after ACTH stimulation test at baseline and at Week 8 in participants with uncontrolled hypertension.
Phase:
PHASE2
Details
Lead Sponsor:
AstraZeneca